Literature DB >> 7221858

Fever and cerebral vasospasm in ruptured intracranial aneurysms.

P Rousseaux, B Scherpereel, M H Bernard, J P Graftieaux, J F Guyot.   

Abstract

The temperature curves of 262 patients affected by subarachnoid hemorrhage, including 107 arterial aneurysms, 26 arteriovenous malformations, 42 idiopathic subarachnoid hemorrhages, and 87 cerebral hemorrhages, were observed and classified into three types: Type I: absence of fever; Type II: fever oscillating between 37 degrees and 38 degrees C; and Type III: fever with a plateau between 38 degrees and 39 degrees C beginning on the fifth day at the latest and lasting an average of nine days, with a decline over the next three days. Type III was observed in 3.8% of the patients with arteriovenous malformations, 7% of those with cerebral hemorrhages, and 88.3% of those who had arterial aneurysms with severe angiographic vasospasm associated with delayed ischemic signs. We suggest that the delayed fever is not a simple sign of meningeal syndrome but a sign related to cerebral vasospasm.

Entities:  

Mesh:

Year:  1980        PMID: 7221858

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  11 in total

1.  Grading and outcome prediction of cases of aneurysmal subarachnoid haemorrhage by bedside xenon cerebral blood flowmetry.

Authors:  M M Kotb; L Symon; J Compton; J Rosenstein; A Jabre
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.

Authors:  Alan K H Tam; Don Ilodigwe; Jay Mocco; Stephan Mayer; Neal Kassell; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Alberto Pasqualin; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

3.  Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter.

Authors:  Neeraj Badjatia; Joan O'Donnell; John R Baker; David Huang; Cenk Ayata; David M Greer; Bob S Carter; Christopher S Ogilvy; Colin T McDonald
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  Temperature rhythm in aneurysmal subarachnoid hemorrhage.

Authors:  Catherine J Kirkness; Robert L Burr; Hilaire J Thompson; Pamela H Mitchell
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors.

Authors:  Alejandro A Rabinstein; Kirsten Sandhu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-11       Impact factor: 10.154

6.  A Propensity Score-Matched Study of the Use of Non-steroidal Anti-inflammatory Agents Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Farshad Nassiri; George M Ibrahim; Jetan H Badhiwala; Christopher D Witiw; Alireza Mansouri; Naif M Alotaibi; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

Review 7.  Inflammation, cerebral vasospasm, and evolving theories of delayed cerebral ischemia.

Authors:  Kevin R Carr; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-08-22

8.  Influence of Fever and hospital-acquired infection on the incidence of delayed neurological deficit and poor outcome after aneurysmal subarachnoid hemorrhage.

Authors:  G Logan Douds; Bi Tadzong; Akash D Agarwal; Satish Krishnamurthy; Erik B Lehman; Kevin M Cockroft
Journal:  Neurol Res Int       Date:  2012-10-02

Review 9.  Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage.

Authors:  Brandon A Miller; Nefize Turan; Monica Chau; Gustavo Pradilla
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

Review 10.  The role of inflammation and potential use of sex steroids in intracranial aneurysms and subarachnoid hemorrhage.

Authors:  Jack W Barrow; Nefize Turan; Pasang Wangmo; Anil K Roy; Gustavo Pradilla
Journal:  Surg Neurol Int       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.